[Cutaneous vasculitis during pergolide mesylate treatment].
Serratrice
J
J
Granel
B
B
Disdier
P
P
Weiller
P J
PJ
Alcaraz
P
P
Azulay
J P
JP
Jean-Pastor
M J
MJ
D000368:Aged; D018491:Dopamine Agonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010479:Pergolide / Q000009:adverse effects*; D011379:Prognosis; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced*
D018491:Dopamine Agonists; D010479:Pergolide